Health Evidence Knowledge Accelerator (HEvKA) Daily Progress July 1, 2024

0 views
Skip to first unread message

Brian Alper

unread,
Jul 1, 2024, 4:35:29 PM7/1/24
to Joanne Dehnbostel, Health Evidence Knowledge Accelerator (HEvKA)

9 people (BA, CE, HL, KS, KW, MA, PRS, PW, SD) participated in up to 3 active working group meetings. 

 

The Project Management Working Group reviewed developments with the leadership of the Core Outcome Measures in Effectiveness Trials (COMET) Initiative to explore areas of mutual interest. They were looking for AI tools to detect outcomes reported in study publications and we suggested checking with PICO Portal

 

The Setting the Scientific Record on FHIR Working Group discussed challenges with server package setup to apply changes to improve the performance of index and search functions on the FEvIR Platform

 

The Statistics Terminology Working Group reviewed two comments regarding p-value. In response to a comment suggesting addition of a comment for the ‘Bayesian p-value’ we added a comment and also added a new term (posterior predictive p-value). In response to a comment regarding clarifying the ‘null hypothesis’ we discussed defining the null hypothesis and started with a definition of its parent term (hypothesis test attribute).  We discussed whether we should move ‘hypothesis test attribute’ to become a type of study design feature but did not decide to move it. We also discussed coordinating the ‘TBD’ codes with newly created STATO codes and will consider rescheduling the weekly Ontology Management Working Group meetings. There are currently 5 statistic terms open for voting: 

 

Term

Definition

Alternative Terms

(if any)

Comment for application

(if any)

hypothesis testing measure

A statistic that represents the relative support for competing hypotheses, based on the observed data under an assumed modeling framework.

  • hypothesis testing statistic
  • hypothesis test statistic

A hypothesis testing measure may be used within the frequentist framework (Neyman-Pearson framework) or the Bayesian framework. Within the frequentist framework, the criterion for rejecting the null hypothesis is typically expressed as a p-value that is less than an alpha setting. Within the Bayesian framework, the approach for rejecting the null hypothesis is typically based on a Bayes factor.

p-value

A hypothesis testing measure that represents the probability of obtaining a result at least as extreme as that actually obtained, assuming the null hypothesis is true.

  • p value
  • P value
  • P-value

Hypothesis testing measure is defined as a statistic that represents the result of evaluating the congruence between a hypothesis and the statistics derived from the observed data.

Within the frequentist framework, the criterion for rejecting the null hypothesis is typically expressed as a p-value that is less than an alpha setting.

Within the Bayesian framework, use the posterior predictive p-value.

p-value for one-sided test

A p-value which represents the probability of obtaining a result at least as extreme, in one direction, as that actually obtained.

  • p-value for one-tailed test
  • one-sided p-value
  • one-tailed p-value

P-value is defined as a hypothesis testing measure that represents the probability of obtaining a result at least as extreme as that actually obtained, assuming the null hypothesis is true. A p-value for one-sided test interprets 'at least as extreme as' without attention to the absolute value of the result. The null hypothesis is expressed with a single threshold.

posterior predictive p-value

A hypothesis testing measure that is the predictive probability that a statistic is equal to or more extreme than that observed under the assumptions of the model.

  • Bayesian p-value

Hypothesis testing measure is defined as a statistic that represents the result of evaluating the congruence between a hypothesis and the statistics derived from the observed data.

hypothesis test attribute

An aspect, characteristic, or feature of a statistical hypothesis test.

 

To participate you can join the Scientific Evidence Code System (SEVCO) Expert Working Group at https://fevir.net/resources/Project/27845.

 

 

Quote for Thought: “Motivation may be what starts you off, but it’s habit that keeps you going back for more.”  ―Miya Yamanouchi



To get involved or stay informed: HEvKA Project Page on FEvIR Platform, HEvKA Project Page on HL7 Confluence, or join any of the groups that are now meeting in the following weekly schedule:

Weekly Meeting Schedule and Link:

 

Day

Time (Eastern)

Team

Monday 

8-9 am 

Project Management

Monday

9-10 am

Setting the Scientific Record on FHIR WG

Monday 

2-3 pm 

Statistic Terminology WG

Tuesday

9-10 am

Measuring the Rate of Scientific Knowledge Transfer WG

Tuesday 

2-3 pm 

StatisticsOnFHIR WG (a CDS EBMonFHIR sub-WG)

Tuesday

3-4 pm

Ontology Management WG

Wednesday

8-9 am 

Funding the Ecosystem Infrastructure WG

Wednesday

9-10 am 

Communications(Awareness, Scholarly Publications) WG

Thursday

8-9 am

EBM Implementation Guide WG (a CDS EBMonFHIR sub-WG)

Thursday

9-10 am

Computable EBM Tools Development WG

Friday

9-10 am 

Risk of Bias Terminology WG

Friday

10-11 am 

GRADE Ontology WG

Friday

12-1 pm

Project Management

 

To join any of these meetings:

________________________________________________________________________________

Microsoft Teams meeting

Join on your computer, mobile app or room device

Click here to join the meeting *New Link!

Meeting ID: 279 232 517 719
Passcode: 8pCpbF

Download Teams | Join on the web

Or call in (audio only)

+1 929-346-7156,,35579956#   United States, New York City

Phone Conference ID: 355 799 56#

Find a local number

Meeting support by ComputablePublishing.com

 

 

 

horizontal bar

Brian S. Alper, MD, MSPH, FAAFP, FAMIA

CEO, Computable Publishing LLC

bal...@computablepublishing.com

 

A picture containing text

Description automatically generated

 

Making Science Machine-Interpretable
http://computablepublishing.com 

 

Lead, HEALTH EVIDENCE KNOWLEDGE ACCELERATOR

President, Scientific Knowledge Accelerator Foundation

 

Read about The Mission Change of a Lifetime

"It only takes a pebble to start an avalanche."

Schedule a meeting with me.

 

The views and opinions included in this email belong to their author and do not necessarily mirror the views and opinions of the company. Our employees are obliged not to make any defamatory clauses, infringe, or authorize infringement of any legal right. Therefore, the company will not take any liability for such statements included in emails. In case of any damages or other liabilities arising, employees are fully responsible for the content of their emails.
Reply all
Reply to author
Forward
0 new messages